Contact
Please use this form to send email to PR contact of this press release:
RedHill Biopharma Announces Enrollment of Last Patient in the BEKINDA® Phase II Study for IBS-D
TO:
Please use this form to send email to PR contact of this press release:
RedHill Biopharma Announces Enrollment of Last Patient in the BEKINDA® Phase II Study for IBS-D
TO: